The role of  N-glycans  in colorectal cancer progression: potential biomarkers and therapeutic applications

Julio Cesar Madureira de Freitas Junior; José Andrés Morgado-Díaz

doi:10.18632/oncotarget.6283

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications

Julio Cesar Madureira de Freitas Junior _ and José Andrés Morgado-Díaz

PDF | HTML | How to cite

Oncotarget. 2016; 7:19395-19413. https://doi.org/10.18632/oncotarget.6283

Metrics: PDF 4649 views | HTML 4224 views | ?

Abstract

Julio Cesar Madureira de Freitas Junior1 and José Andrés Morgado-Díaz1

1 Cellular Biology Program, Structural Biology Group, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil

Correspondence to:

Julio Cesar Madureira de Freitas Junior, email:

José Andrés Morgado-Díaz, email:

Keywords: N-glycans, colorectal cancer, biomarkers, glycosylation, carcinoma

Received: May 28, 2015 Accepted: October 22, 2015 Published: November 02, 2015

Abstract

Changes in glycosylation, which is one of the most common protein post-translational modifications, are considered to be a hallmark of cancer. N-glycans can modulate cell migration, cell-cell adhesion, cell signaling, growth and metastasis. The colorectal cancer (CRC) is a leading cause of cancer-related mortality and the correlation between CRC progression and changes in the pattern of expression of N-glycans is being considered in the search for new biomarkers. Here, we review the role of N-glycans in CRC cell biology. The perspectives on emerging N-glycan-related anticancer therapies, along with new insights and challenges, are also discussed.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6283

Publication Alerts

Reviews:

The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications

Abstract